↓ Skip to main content

Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma

Overview of attention for article published in Cochrane database of systematic reviews, April 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

policy
2 policy sources
twitter
1 tweeter
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
130 Dimensions

Readers on

mendeley
227 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma
Published in
Cochrane database of systematic reviews, April 2010
DOI 10.1002/14651858.cd005533.pub2
Pubmed ID
Authors

Francine M Ducharme, Muireann Ni Chroinin, Ilana Greenstone, Toby J Lasserson

Abstract

In asthmatic patients inadequately controlled on inhaled corticosteroids and/or those with moderate persistent asthma, two main options are recommended: the combination of a long-acting inhaled ss2 agonist (LABA) with inhaled corticosteroids (ICS) or use of a higher dose of inhaled corticosteroids.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 227 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 <1%
Ireland 1 <1%
Korea, Republic of 1 <1%
South Africa 1 <1%
United Kingdom 1 <1%
Colombia 1 <1%
Unknown 220 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 38 17%
Researcher 35 15%
Student > Bachelor 28 12%
Other 24 11%
Student > Ph. D. Student 23 10%
Other 46 20%
Unknown 33 15%
Readers by discipline Count As %
Medicine and Dentistry 110 48%
Nursing and Health Professions 23 10%
Pharmacology, Toxicology and Pharmaceutical Science 15 7%
Social Sciences 8 4%
Psychology 7 3%
Other 22 10%
Unknown 42 19%

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 December 2017.
All research outputs
#2,297,154
of 17,353,889 outputs
Outputs from Cochrane database of systematic reviews
#5,025
of 11,661 outputs
Outputs of similar age
#22,455
of 162,444 outputs
Outputs of similar age from Cochrane database of systematic reviews
#47
of 126 outputs
Altmetric has tracked 17,353,889 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,661 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 25.0. This one has gotten more attention than average, scoring higher than 56% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 162,444 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 126 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.